Evidence map›Paper›PMID 41971184›Full record

ArticleReproductive medicine and biology

Uterine Endometrial Microbiome and Chronic Endometritis in Relation to Anti-β2-Glycoprotein I (β2GPI)/Human Leukocyte Antigen (HLA)-DR Autoantibodies in Women With Recurrent Implantation Failure and Recurrent Pregnancy Loss: A Cross-Sectional Study.

Yosuke Ono, Hajime Ota, Maki Ogi, Yoshiyuki Fukushi, Shinichiro Wada, Hisashi Arase, Osamu Yoshino, Hideto Yamada

Abstract read
In one paragraph

Article in Reproductive medicine and biology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yosuke OnoDepartment of Obstetrics and Gynecology University of Yamanashi Chuo Yamanashi Japan.
Hajime OtaDepartment of Obstetrics and Gynecology Teine Keijinkai Hospital Sapporo Japan.
Maki OgiDepartment of Obstetrics and Gynecology University of Yamanashi Chuo Yamanashi Japan.
Yoshiyuki FukushiDepartment of Obstetrics and Gynecology Teine Keijinkai Hospital Sapporo Japan.
Shinichiro WadaDepartment of Obstetrics and Gynecology Teine Keijinkai Hospital Sapporo Japan.
Hisashi AraseLaboratory of Immunochemistry, World Premier International Immunology Frontier Research Center The University of Osaka Suita Osaka Japan.
Osamu YoshinoDepartment of Obstetrics and Gynecology University of Yamanashi Chuo Yamanashi Japan.ORCID https://orcid.org/0000-0001-6942-3018
Hideto YamadaCenter for Recurrent Pregnancy Loss Teine Keijinkai Hospital Sapporo Japan.ORCID https://orcid.org/0000-0001-9839-2214

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Anti-β2GPI/HLA-DR autoantibodies may be involved in recurrent implantation failure (RIF) and recurrent pregnancy loss (RPL). We examined their association with the endometrial microbiome and chronic endometritis (CE). Methods: In this cross-sectional study, 141 women (54 RIF, 87 RPL) were enrolled. Serum anti-β2GPI/HLA-DR positivity was defined using 99th/95th percentile cut-offs. Endometrial microbiome was assessed by 16S rRNA sequencing, focusing on reproductive-failure-related species ( Results: In RIF, antibody-positive women more frequently had Conclusion: Anti-β2GPI/HLA-DR antibody positivity was associated with endometrial dysbiosis and may serve as a biomarker of abnormal intrauterine environment in reproductive failure.

Indexed as

endometrial microbiomeHLA‐DRrecurrent implantation failurerecurrent pregnancy lossβ2‐glycoprotein I

Identifiers

PMID41971184
PMCPMC13066496

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.